The GSK Vaccines Access Program has temporarily suspended enrollment of patients into our Program for Cervarix as of 9/15/2014 and Boostrix as of 9/29/2014. This temporary suspension has been caused by a product supply issue that has been identified. This issue only affects the Cervarix and Boostrix package of 1, which are only available for the Vaccines Access Program. This shortage does not have any effect on the supply of Cervarix and Boostrix in the commercial market. We apologize for any inconvenience.
Effective 9/17/2014 Havrix is available again in the GSK Vaccines Access Program.
All updates on program status will be posted to this website. Questions regarding the GSK Vaccines Access Program can be addressed by calling Program representatives at 1?877?VACC?911, M?F, 9:00am?7:00pm ET.
GSK Vaccines Access Program is a patient assistance program sponsored by GlaxoSmithKline that provides GlaxoSmithKline vaccines to adult applicants who meet eligibility requirements. This program does not constitute health insurance
There are three easy steps to providing free vaccine to eligible patients: